Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 195

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes

Open access
Patel, Kashyap A., Oram, Richard A., Flanagan, Sarah E., De Franco, Elisa, Colclough, Kevin, Shepherd, Maggie, Ellard, Sian, Weedon, Michael N., Hattersley, Andrew T. · 2016 · Diabetes

Abstract

Distinguishing patients with monogenic diabetes from those with type 1 diabetes (T1D) is important for correct diagnosis, treatment, and selection of patients for gene discovery studies. We assessed whether a T1D genetic risk score (T1D-GRS) generated from T1D-associated common genetic variants provides a novel way to discriminate monogenic diabetes from T1D. The T1D-GRS was highly discriminative of proven maturity-onset diabetes of young (MODY) (n = 805) and T1D (n = 1,963) (receiver operating characteristic area under the curve 0.87). A T1D-GRS of >0.280 (>50th T1D centile) was indicative of T1D (94% specificity, 50% sensitivity). We then analyzed the T1D-GRS of 242 white European patients with neonatal diabetes (NDM) who had been tested for all known NDM genes. Monogenic NDM was confirmed in 90, 59, and 8% of patients with GRS <5th T1D centile, 50–75th T1D centile, and >75th T1D centile, respectively. Applying a GRS 50th T1D centile cutoff in 48 NDM patients with no known genetic cause identified those most likely to have a novel monogenic etiology by highlighting patients with probable early-onset T1D (GRS >50th T1D centile) who were diagnosed later and had less syndromic presentation but additional autoimmune features compared with those with proven monogenic NDM. The T1D-GRS is a novel tool to improve the use of biomarkers in the discrimination of monogenic diabetes from T1D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db15-1690

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 18

  1. McCarthy, 2008, Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes, Diabetes, 57, 2889, 10.2337/db08-0343 · DOI
  2. Onengut-Gumuscu, 2015, Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers, Nat Genet, 47, 381, 10.1038/ng.3245 · DOI · Paper page
  3. Bradfield, 2011, A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci, PLoS Genet, 7, e1002293, 10.1371/journal.pgen.1002293 · DOI · Paper page
  4. Winkler, 2014, Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes, Diabetologia, 57, 2521, 10.1007/s00125-014-3362-1 · DOI
  5. Oram, 2016, A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults, Diabetes Care, 10.2337/dc15-1111 · DOI · Paper page
  6. Törn, 2015, Role of type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY Study, Diabetes, 10.2337/db14-1497 · DOI
  7. Ellard, 2013, Improved genetic testing for monogenic diabetes using targeted next-generation sequencing, Diabetologia, 56, 1958, 10.1007/s00125-013-2962-5 · DOI · Paper page
  8. McDonald, 2011, Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from type 1 diabetes, Diabet Med, 28, 1028, 10.1111/j.1464-5491.2011.03287.x · DOI · Paper page
  9. Decochez, 2000, High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry, Diabetes Care, 23, 838, 10.2337/diacare.23.6.838 · DOI
  10. Besser, 2011, Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-α/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes, Diabetes Care, 34, 286, 10.2337/dc10-1293 · DOI
  11. Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes, Diabetologia, 55, 1265, 10.1007/s00125-011-2418-8 · DOI · Paper page
  12. Talmud, 2013, Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study, Lancet, 381, 1293, 10.1016/S0140-6736(12)62127-8 · DOI · Paper page
  13. Edghill, 2006, HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months, Diabetes, 55, 1895, 10.2337/db06-0094 · DOI
  14. Iafusco, 2002, Permanent diabetes mellitus in the first year of life, Diabetologia, 45, 798, 10.1007/s00125-002-0837-2 · DOI
  15. Chang, 2012, Neonatal autoimmune diseases: a critical review, J Autoimmun, 38, J223, 10.1016/j.jaut.2011.11.018 · DOI
  16. Flanagan, 2014, Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease, Nat Genet, 46, 812, 10.1038/ng.3040 · DOI · Paper page
  17. Krischer, 2015, The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study, Diabetologia, 58, 980, 10.1007/s00125-015-3514-y · DOI · Paper page
  18. Lernmark, 2013, Immune therapy in type 1 diabetes mellitus, Nat Rev Endocrinol, 9, 92, 10.1038/nrendo.2012.237 · DOI

Cited by

See all 195

Metadata

Authors
Patel, K. A., Oram, R. A., Flanagan, S. E., De Franco, E., Colclough, K., Shepherd, M., Ellard, S., Weedon, M. N., & Hattersley, A. T.
Venue
Diabetes
Published
2016-04-05
Volume
65
Issue
7
Pages
2094-2099
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2313889229
Cited by
195
References
8
FWCI
16.14
Type
journal article
Language
en
Open access
green
Funders
Wellcome Trust (076113)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/db15-1690
The paper
Patel, K. A., Oram, R. A., Flanagan, S. E., De Franco, E., Colclough, K., Shepherd, M., Ellard, S., Weedon, M. N., & Hattersley, A. T. (2016). Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db15-1690

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.